Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
Centogene AG - the Rare Disease Company Germany | 323 | 329 |
|
Centogene AG - the Rare Disease Company Germany | 498 | 498 |
|
Centogene AG - the Rare Disease Company Germany | 499 | 499 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Centogene AG - the Rare Disease Company Germany | 828 | 848 |
|
Invitae Neonatal Respiratory Distress Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 163 | 111 |
|
Heterotaxy, Situs Inversus and Kartagener's Syndrome Panel PreventionGenetics, part of Exact Sciences United States | 43 | 48 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 162 | 129 |
|
Primary Ciliary Dyskinesia (PCD)/Immotile Cilia Syndrome Panel PreventionGenetics, part of Exact Sciences United States | 44 | 50 |
|
Primary Ciliary Dyskinesia (PCD) via the ODAD1/CCDC114 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 135 | 133 |
|
Primary Ciliary Dyskinesia (PCD)/Immotile Cilia Syndrome and Cystic Fibrosis Panel PreventionGenetics, part of Exact Sciences United States | 44 | 51 |
|
Plugin system clutter panel. NGS panel of 75 genes. Genologica Medica Spain | 76 | 75 |
|
Ciliary dyskinesia and heterotaxia. NGS panel of 40 genes. Genologica Medica Spain | 49 | 40 |
|
Primary ciliary dyskinesia panel. 36-gene NGS panel. Genologica Medica Spain | 46 | 35 |
|
Heterotaxy and situs inversus panel. 32-gene NGS panel. Genologica Medica Spain | 34 | 31 |
|
Asper Biogene Asper Biogene LLC Estonia | 166 | 120 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.